The Value of Optical Coherence Tomography Angiography (OCT-A) in Neurological Diseases

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Feb 25

PMID 35204559

Authors

Albert J Augustin

Jenny Atorf

Affiliations

Soon will be listed here.

Abstract

Optical coherence tomography angiography (OCT-A) was commercially introduced in 2014. OCT-A allows a fast, non-invasive, three-dimensional analysis of the retinal vasculature from the vitreoretinal interface to the choriocapillaris. The results can be evaluated separately in automated or custom-defined retinal layers. Since its introduction, OCT-A has also been used in patients with neurological diseases in order to find and characterize retinal biomarkers. Many neurological diseases have retinal manifestations, often preceding the key symptoms of the neurological disease. Anatomically and developmentally, the retina is a part of the brain. In contrast to the brain, the retina is easily accessible for imaging methods; moreover, retinal imaging is more cost-effective than brain imaging. In this review, the current knowledge about OCT-A findings and possible OCT-A biomarkers in neurological diseases is summarized and discussed regarding the value of OCT-A as a diagnostic tool in neurological diseases.

Citing Articles

Optical coherence tomography angiography in patients with focal epilepsy.

Rider F, Guekht A, Shpak A Front Neurol. 2025; 16:1529409.

PMID: 39944552 PMC: 11816351. DOI: 10.3389/fneur.2025.1529409.

Using optical coherence tomography and optical coherence tomography angiography to delineate neurovascular homeostasis in migraine: a review.

Chaliha D, Vaccarezza M, Charng J, Chen F, Lim A, Drummond P Front Neurosci. 2024; 18:1376282.

PMID: 38686331 PMC: 11057254. DOI: 10.3389/fnins.2024.1376282.

Associations between the retinal/choroidal microvasculature and carotid plaque in patients with CAD: An OCTA study.

Jiang J, Wang J, Wang Y, Wang L, Qian Y, Wang Z Heliyon. 2024; 10(7):e29107.

PMID: 38623223 PMC: 11016606. DOI: 10.1016/j.heliyon.2024.e29107.

[Retinal OCT biomarkers and neurodegenerative diseases of the central nervous system beyond Alzheimer's disease].

Hopf S, Tuscher O, Schuster A Ophthalmologie. 2024; 121(2):93-104.

PMID: 38263475 DOI: 10.1007/s00347-023-01974-7.

Innovative Macula Capillaries Plexuses Visualization with OCTA B-Scan Graph Representation: Transforming OCTA B-Scan into OCTA Graph Representation.

Al-Hinnawi A, Al-Latayfeh M, Tavakoli M J Multidiscip Healthc. 2023; 16:3477-3491.

PMID: 38024137 PMC: 10662934. DOI: 10.2147/JMDH.S433405.

References

Zou J, Liu K, Li F, Xu Y, Shen L, Xu H . Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease. Quant Imaging Med Surg. 2020; 10(10):1930-1939. PMC: 7495313. DOI: 10.21037/qims-20-460. View

Gupta S, Zivadinov R, Ramanathan M, Weinstock-Guttman B . Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?. Expert Rev Neurother. 2016; 16(7):765-75. DOI: 10.1080/14737175.2016.1180978. View

Molero-Senosiain M, Vidal-Villegas B, Pascual-Prieto J, Valor-Suarez C, Saenz-Frances F, Santos-Bueso E . Correlation Between Retrograde Trans-Synaptic Degeneration of Ganglion Cells and Optical Coherence Tomography Angiography Following Ischemic Stroke. Cureus. 2021; 13(11):e19788. PMC: 8693543. DOI: 10.7759/cureus.19788. View

Jiang H, Gameiro G, Liu Y, Lin Y, Hernandez J, Deng Y . Visual Function and Disability Are Associated with Increased Retinal Volumetric Vessel Density in Patients with Multiple Sclerosis. Am J Ophthalmol. 2020; 213:34-45. PMC: 7214204. DOI: 10.1016/j.ajo.2019.12.021. View

Kaplan A, Oskan Yalcin S, Sager S . Evaluation of optical coherence tomography findings in adolescents with genetic generalized epilepsy. Eur J Ophthalmol. 2021; 32(6):3650-3656. DOI: 10.1177/11206721211049710. View

Cordon B, Vilades E, Orduna E, Satue M, Perez-Velilla J, Sebastian B . Angiography with optical coherence tomography as a biomarker in multiple sclerosis. PLoS One. 2020; 15(12):e0243236. PMC: 7723290. DOI: 10.1371/journal.pone.0243236. View

Rascuna C, Russo A, Terravecchia C, Castellino N, Avitabile T, Bonfiglio V . Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease. Front Neurol. 2020; 11:533375. PMC: 7575742. DOI: 10.3389/fneur.2020.533375. View

Murueta-Goyena A, Barrenechea M, Erramuzpe A, Teijeira-Portas S, Pengo M, Ayala U . Foveal Remodeling of Retinal Microvasculature in Parkinson's Disease. Front Neurosci. 2021; 15:708700. PMC: 8311167. DOI: 10.3389/fnins.2021.708700. View

Katan M, Luft A . Global Burden of Stroke. Semin Neurol. 2018; 38(2):208-211. DOI: 10.1055/s-0038-1649503. View

10.

Avery M, Magal I, Kherani A, Mitha A . Risk of Stroke in Patients With Ocular Arterial Occlusive Disorders: A Retrospective Canadian Study. J Am Heart Assoc. 2019; 8(3):e010509. PMC: 6405587. DOI: 10.1161/JAHA.118.010509. View

11.

Paul K, Jerrett M, Ritz B . Type 2 Diabetes Mellitus and Alzheimer's Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors. Curr Environ Health Rep. 2018; 5(1):44-58. PMC: 5931378. DOI: 10.1007/s40572-018-0176-1. View

12.

Spain R, Liu L, Zhang X, Jia Y, Tan O, Bourdette D . Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis. Br J Ophthalmol. 2017; 102(4):520-524. PMC: 6467481. DOI: 10.1136/bjophthalmol-2017-310477. View

13.

Bingol Kiziltunc P, Ozcan G, Ozer F, Togay Isikay C, Atilla H . Evaluation of retinal vessel density and choriocapillaris flow in migraine patients with and without aura. Graefes Arch Clin Exp Ophthalmol. 2020; 258(11):2517-2521. DOI: 10.1007/s00417-020-04805-6. View

14.

Robbins C, Thompson A, Bhullar P, Koo H, Agrawal R, Soundararajan S . Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease. JAMA Ophthalmol. 2020; 139(2):182-188. PMC: 7758829. DOI: 10.1001/jamaophthalmol.2020.5730. View

15.

Heng L, Bailey C, Lee R, Dick A, Ross A . A review and update on the ophthalmic implications of Susac syndrome. Surv Ophthalmol. 2019; 64(4):477-485. DOI: 10.1016/j.survophthal.2019.01.007. View

16.

Tsokolas G, Tsaousis K, Diakonis V, Matsou A, Tyradellis S . Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review. Eye Brain. 2020; 12:73-87. PMC: 7368556. DOI: 10.2147/EB.S193026. View

17.

Leclaire M, Eter N, Alnawaiseh M . [Optical coherence tomography angiography and cardiovascular diseases. An overview of the current knowledge]. Ophthalmologe. 2021; 118(11):1119-1127. PMC: 8568759. DOI: 10.1007/s00347-021-01336-1. View

18.

Alten F, Motte J, Ewering C, Osada N, Clemens C, Kadas E . Multimodal retinal vessel analysis in CADASIL patients. PLoS One. 2014; 9(11):e112311. PMC: 4221286. DOI: 10.1371/journal.pone.0112311. View

19.

London A, Benhar I, Schwartz M . The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2012; 9(1):44-53. DOI: 10.1038/nrneurol.2012.227. View

20.

Chang M, Phasukkijwatana N, Garrity S, Pineles S, Rahimi M, Sarraf D . Foveal and Peripapillary Vascular Decrement in Migraine With Aura Demonstrated by Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2017; 58(12):5477-5484. PMC: 5656414. DOI: 10.1167/iovs.17-22477. View